FDA Carves Out Broad Powers In Drug Inspections
The U.S. Food and Drug Administration is asserting broad investigative powers in new guidance describing how it polices drugmakers, claiming wide authority to seize shoddy products if a manufacturer tries to...To view the full article, register now.
Already a subscriber? Click here to view full article